Immunotherapy & Oncology
Cancer treatment has moved from poisoning dividing cells towards directing the immune system at the tumour, and towards drugs that carry their payload only to cancerous tissue. It absorbs more drug development spending than any other area.
388 stocks
Increased
Reduced
Net increased
Funds Holding
4,948
Funds Holding Change
-88
Funds Holding Growth
-2%
Value
$1.47T
Holding in Top 10
1,266
Top 10 Change
-356
Top 10 Growth
-22%
Value Growth
-5%
New
158
Increased
2,104
Reduced
2,354
Closed
142
Capital Inflow
$55.5B
Capital Outflow
$37.6B
Net Capital Flow
+$17.9B
Capital Flow Change
+$863M
Calls
$18.4B
Puts
$15.4B
Net Calls
+$2.98B
Put/Call Ratio
0.84